|Venture Round, 10/12 ||$500k|
CanDiag, Inc. is a University of North Carolina Charlotte (UNCC) spin-off that was incorporated in November 2010. Dr. Pinku Mukherjee, Irwin Belk Endowed Professor for Cancer Research at UNCC, is the founder of CanDiag. They have a worldwide exclusive license to a patented tumor antibody that has been used to develop a blood test for the early detection of breast cancer. Their vision is to expand their capabilities and offer services and products ranging from accurate cancer screening kits to targeted drug delivery systems for cancers that affect men and women.